Medinotec (MDNC) Gross Margin (2022 - 2026)
Medinotec posted quarterly Gross Margin of 53.06% for Q4 2025, up 1248.0% year-on-year from 3.94% in Q4 2024, and down 14.24% on a QoQ basis from 61.87% in Q3 2025.
Medinotec (MDNC) has 4 years of Gross Margin data on file, last reported at 53.06% in Q4 2025.
- For the quarter ending Q4 2025, Gross Margin rose 1248.0% year-over-year to 53.06%; the trailing twelve-month figure through Nov 2025 stood at 58.25% (up 1448.0% YoY), and the FY2025 full-year result was 53.34%, up 468.0% from the prior year.
- Gross Margin for Q4 2025 stood at 53.06%, down from 61.87% in the prior quarter.
- Across five years, Gross Margin topped out at 82.61% in Q3 2023 and bottomed at 40.58% in Q4 2024.
- The 4-year median for Gross Margin is 56.89% (2022), against an average of 57.4%.
- The widest annual swing landed in 2024, when Gross Margin slumped 3642 bps; it then jumped 2455 bps in 2025.
- A 4-year view of Gross Margin shows it stood at 57.55% in 2022, then fell by 25 bps to 43.14% in 2023, then fell by 6 bps to 40.58% in 2024, then jumped by 31 bps to 53.06% in 2025.
- The last three Gross Margin figures came in at 53.06% (Q4 2025), 61.87% (Q3 2025), and 43.36% (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 63.83% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 78.01% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 45.22% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 62.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 38.53% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 43.89% |
| 10 | Medinotec | - | - | 854,557.00 | 46.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 46.90% |
| Nov 30, 2025 | 53.06% |
| Aug 31, 2025 | 61.87% |
| May 31, 2025 | 43.36% |
| Feb 28, 2025 | 67.69% |
| Nov 30, 2024 | 40.58% |
| Aug 31, 2024 | 46.20% |
| May 31, 2024 | 47.95% |
| Feb 29, 2024 | 43.14% |
| Nov 30, 2023 | 43.14% |
| Aug 31, 2023 | 82.61% |
| May 31, 2023 | 76.33% |
| Feb 28, 2023 | 57.88% |
| Nov 30, 2022 | 57.55% |
| Aug 31, 2022 | 63.62% |
| May 31, 2022 | 56.22% |
| Feb 28, 2022 | 77.15% |